← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #902 OF 1,000 MOST-CITED

Records - supervisory review

FDA cited this observation 16 times across 13 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods16
BY FISCAL YEAR
FY20261
FY20254
FY20241
FY20233
FY20224
FY20211
FY20182

How FDA worded it — real examples

Your required records were not reviewed, dated, and signed by a supervisor or responsible party within a reasonable time after the records are made.

Schlechter Farms Inc · Salem, Oregon · Foods · 2025-12-19

Your required records were not reviewed, dated, and signed by a supervisor or responsible party within a reasonable time after the records are made.

Enoki King Mushroom Farm Inc. · Ventura, California · Foods · 2025-08-21

Your required records were not reviewed, dated, and signed by a supervisor or responsible party within a reasonable time after the records are made.

Lone Palm, Inc. · Hawi, Hawaii · Foods · 2025-06-25

Your required records were not reviewed, dated, and signed by a supervisor or responsible party within a reasonable time after the records are made.

L & H Bean Sprouts Company · Oklahoma City, Oklahoma · Foods · 2025-05-08

Your required records were not reviewed, dated, and signed by a supervisor or responsible party within a reasonable time after the records are made.

L & L AG Production LLC. · Connell, Washington · Foods · 2024-11-04

Your required records were not reviewed, dated, and signed by a supervisor or responsible party within a reasonable time after the records are made.

Alfred Louie Inc · Bakersfield, California · Foods · 2024-02-20

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →